Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2025-12-26 @ 2:00 AM
NCT ID:
NCT01698905
Group ID:
EG000
Title:
NTCS Phase
Description:
Patients with minimum 3 years of tyrosine kinase inhibitor treatment (first with imatinib and then switched to nilotinib) since initial diagnosis, at least 2 years of nilotinib treatment prior to study entry and who achieved MR4.5 (local laboratory assessment) during nilotinib treatment, and determined by a Novartis designated central PCR lab assessment at screening
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
21
Serious Number At Risk:
163
Other Number Affected:
80
Other Number At Risk:
163
Study:
NCT01698905
Results Section:
NCT01698905
Adverse Events Module:
NCT01698905